By Stefan Krueger, Long-Term & Business Model desk. Reviewed prior to publication on 2026-06-27, 15:04.
Hikma Pharmaceuticals PLC (GB00B128J450) sits at the intersection of branded and generic medicines in key markets across the Middle East, Europe and the United States. The London-listed group has built a long-term growth profile around injectables, generic oral therapies and branded pharmaceuticals, backed by recurring demand for essential medicines.
How Hikma earns its revenue
Hikma reports its business across three main segments:…
